On lighter skin, plaque psoriasis can appear red ... Hartman says that lesions from psoriasis can leave spots of discoloration or post-inflammatory dyspigmentation for months after a flare ...

Deucravacitinib offers another potential example for optimization. Though approved for moderate or severe plaque psoriasis, ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

A decade-long study found that obesity was associated with a significantly increased risk for biologic treatment failure in ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. | Art Garfunkel is breaking the ...

Though approved for moderate or severe plaque psoriasis, "for me, I think the sweet spot in terms of treating patients with moderate to severe plaque psoriasis is a bit more toward the moderate ...